Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - the elekta medical linear accelerator (emla) is intended to be used for external beam radiation therapy (ebrt) treatments as determined by a licensed medical practitioner. it is intended to assist a licensed medical practitioner in the delivery of ebrt to defined target volumes, while sparing surrounding normal tissue and critical organs from excess radiation. elekta synergy is intended to be used for single or multiple fractions using standard dose fractionation, hyperfractionation, and hypofractionation in all areas of the body where such treatment is indicated. the emla is indicated for the delivery of curative and palliative intent ebrt to adult and pediatric patients with primary benign and malignant tumor and metastasis (or secondaries) anywhere in the body.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

elekta pty ltd - 35159 - accelerator system, linear - the elekta medical linear accelerator (emla) is intended to be used for external beam radiation therapy (ebrt) treatments as determined by a licensed medical practitioner. ? it is intended to assist a licensed practitioner in the delivery of ebrt to defined target volumes, whilst sparing surrounding normal tissue and critical organs from excess radiation. it is intended to be used for single or multiple fractions of standard dose fractions, hyperfractionation, hypofractionation and stereotactic delivery (stereotactic body radiation therapy ? sbrt; stereotactic ablative radiotherapy- sabr; stereotactic radio surgery ? srs); in all areas of the body where such treatment is indicated. ? the emla is indicated for the delivery of curative and palliative intent ebrt to adult and paediatric patients with primary benign and malignant tumors, metastases (or secondaries), and functional indications.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - general hospital - intended for use in planning invasive intra-cranial stereotactic surgical procedures.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - neurology - the neurosurgical instruments are intended for use with leksell stereotactic system® for diagnosis of intracranial disorders and their surgical treatment.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - neurology - the intended purpose of leksell®'s vantage™ stereotactic system is to target localization and fixation of the patient head in a coordinate system in order to perform stereotactic neurosurgical procedures, for example; deep brain stimulation, lesioning, biopsies, targeted injections, aspirations and minimal invasive tumor treatments. in addition, the theleksell®vantage™head frame system is intended to be used for target localization and head fixation during intracranial stereotactic radiosurgery with the leksell gammaknife®.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - the active breathing coordinator™ is indicated for use when there is a need to reduce the anatomical movement in the thorax and abdomen caused by breathing and cardiac motion. it is intended for breath-hold (bh) during simulation and delivery of external beam radiation therapy (ebrt) using photons, in single or multiple fractions, administered via static and/or dynamic delivery processes, in any and all areas of the body where such treatment is indicated. it also provides electrical prompts and status information for the elekta limited response™ gating interface when automated gating of the linac is used.the active breathing coordinator™ is specifically indicated for breast tumors, lung cancers and other thoracic tumors,liver tumors,pancreatic tumors.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - intended to be used for the radiation therapy of defined target volumes anywhere in the body, as determined by a licensed medical practitioner.

Singapura - Inggeris - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - the elekta medical linear accelerator (emla) is intended to be used for external beam radiation therapy (ebrt) treatments as determined by a licensed medical practitioner. it is intended to assist a licensed medical practitioner in the delivery of ebrt to defined target volumes, while sparing surrounding normal tissue and critical organs from excess radiation. versa hd is intended to be used for single or multiple fractions using standard fractionation, hyperfractionation, hypofractionation and stereotactic delivery (stereotactic body radiation therapy – sbrt; stereotactic ablative radiotherapy – sabr; stereotactic radio surgery - srs) in all areas of the body where such treatment is indicated and for the treatment of functional disorders, such as trigeminal neuralgia. the emla is indicated for the delivery of curative and palliative intent ebrt to adult and pediatric patients with primary benign and malignant tumor and metastasis (or secondaries) anywhere in the body.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

elekta pty ltd - 38563 - biopsy kit, brain - these needles are an alternative to reusable biopsy needles addressing concerns regarding cross?contamination. the kit includes a disposable sidecutting biopsy needle with an 8.0 mm needle window and an aspiration tube. the kit also includes a disposable stop and guide to further reduce the risk of crosscontamination. the disposable biopsy needle kit is designed for performing brain biopsies using leksell stereotactic system?. this device should only be used by a physician/surgeon trained in the use of leksell stereotactic system? and brain biopsy needle devices and procedures.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

lek pharmaceuticals - bromocriptine mesylate (unii: ffp983j3od) (bromocriptine - unii:3a64e3g5zo) - tablet - 2.5 mg - bromocriptine mesylate tablets are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. bromocriptine mesylate treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. reduction in tumor size has been demonstrated in both male and female patients with macroadenomas. in cases where adenectomy is elected, a course of bromocriptine mesylate therapy may be used to reduce the tumor mass prior to surgery. acromegaly bromocriptine mesylate tablets are indicated in the treatment of acromegaly. bromocriptine mesylate therapy, alone or as adjunctive therapy with pituitary irradiation or surgery, reduces serum growth hormone by 50% or more in approximately one-half of patients treated, although not usually to normal levels. since the effects of external pituitary radiation may not become maximal for